Edwards Lifesciences Corp
NYSE:EW
Edwards Lifesciences Corp
NYSE:EW
Price:
86.43 USD
-1.8%
Market Closed
Updated:
Apr 29, 2024
Edwards Lifesciences Corp
Cash from Operating Activities
|
Edwards Lifesciences Corp
Cash from Operating Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Cash from Operating Activities
$895.8m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
7%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
52%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Edwards Lifesciences Corp's Cash from Operating Activities?
Cash from Operating Activities
895.8m
USD
895.8m
USD
Based on the financial report for Dec 31, 2023, Edwards Lifesciences Corp's Cash from Operating Activities amounts to 895.8m USD.
What is Edwards Lifesciences Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
7%
7%
Over the last year, the Cash from Operating Activities growth was -26%. The average annual Cash from Operating Activities growth rates for Edwards Lifesciences Corp have been -5% over the past three years , -1% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
